Email
Password
Remember meForgot password?
    Log in with Twitter
Press Release

Global Viral Infections Market Is Expected to Reach $117.6 Billion by 2021; Finds New Report

Market Research Reports, Inc. has announced the addition of “Global Viral Infections Market to 2021 - Promising New Competitors and Expanding Treatment Population to Offset Increased Uptake of Generics” research report to their website www.MarketResearchReports.com

This press release was orginally distributed by SBWire

Lewes, DE -- (SBWIRE) -- 05/20/2016 -- The global viral infections market will grow from $74 billion in 2014 to $117.6 billion by 2021, representing a compound annual growth rate of 6.8%, according to new research report.

The company's latest report states that the expanding treatment population, which has resulted from improved treatment options and global initiatives to improve access to treatment for many people living with chronic debilitating viral infections such as HIV, will be a key driver of this growth. Rising therapy costs resulting from the uptake of recently approved, highly-priced antiviral agents, as well as promising late-stage candidates which are expected to be priced highly, will also be a factor.

According to Senior Analyst, states that: "Some 1,848 pipeline products are specifically in development for the treatment of viral infections, accounting for a sizeable proportion of the infectious diseases pipeline. Among these products, HIV has the most at an active stage of development, with 419, followed by influenza, Hepatitis C and Hepatitis B, with 333, 222 and 150 pipeline products, respectively.

"Such strong activity is indicative of a high degree of commercial interest in viral infections in general, and in these key indications in particular, which reflects the commercial success of currently marketed products such as Truvada, Atripla and Harvoni. However, it should be noted that many products in the viral infections pipeline are being developed for multiple indications, including infectious diseases attributable to non-viral micro-organisms."

Publisher also states that generic penetration is projected to increase considerably over the forecast period, especially in the seven major markets of the US, France, Germany, Italy, the UK, Spain, and Japan.

Senior Analyst continues: "The availability of generic drugs is expected to increase due to a series of recent and upcoming patent expirations for key marketed products, particularly within HIV.

"Due to enhanced cost-consciousness, clinicians will increasingly favor generic drugs over premium products in order to reduce the cost of treatment. However, the strength of innovation will continue to drive the global viral infections space, as demonstrated by the strong growth."

Global Viral Infections Market to 2021 - Promising New Competitors and Expanding Treatment Population to Offset Increased Uptake of Generics report provides analysis of the global viral infections pipeline, stratified by stage of development, molecule type and molecular target. It includes information on the current clinical and commercial landscape, with annualized market data from 2014 and forecast to 2021.

This report was built using data and information sourced from proprietary databases, primary and secondary research, and in-house analysis conducted by Publisher's team of industry experts.

For more information Visit at: http://www.marketresearchreports.com/gbi-research/global-viral-infections-market-2021-promising-new-competitors-and-expanding-treatment

Find all Therapeutic Reports at: http://www.marketresearchreports.com/therapeutic

About Market Research Reports, Inc.
Market Research Reports, Inc. is the world's leading source for market research reports and market data. We provide you with the latest market research reports on global markets, key industries, leading companies, new products and latest industry analysis & trends.

Yearly/Quarterly Report Subscription: http://www.marketresearchreports.com/subscriptions

For more information on this press release visit: http://www.sbwire.com/press-releases/global-viral-infections-market-is-expected-to-reach-1176-billion-by-2021-finds-new-report-691033.htm

Media Relations Contact

Sudeep Chakravarty
Director - Operations
Market Research Reports, Inc.
Telephone: 302-703-7787
Email: Click to Email Sudeep Chakravarty
Web: http://www.marketresearchreports.com/gbi-research/global-viral-infections-market-2021-promising-new-competitors-and-expanding-treatment

Latest News
Top News